Managing Patients With Neurotrophic Keratitis (NK)
* Definition * Epidemiology * Natural history * Patient burden
Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Managing Patients With Neurotrophic Keratitis (NK)-Community!
Dann 4,99 € / Monat · Jederzeit kündbar.
4 Folgen
Patient Education & Cases
* Principles * Case #1 * Case #2 Key Concepts: * Patient education about the disease and its natural history if left untreated is important * Interprofessional, multidisciplinary care is associated with the best patient outcomes
Treatment
* Team-based care * Treatment * General care * Prevention * Symptomatic treatment * Cenegermin * Safety, efficacy, role in treatment/patient selection * Cost * Storage and administration * Corneal neurotization * Investigational therapies Key Concepts: * Most patients should receive basic preventive and symptomatic care, as well as active treatment in certain cases * Cenegermin promotes corneal healing and is the only medication approved for the treatment of patients with neurotrophic keratitis
Screening & Diagnosis
* Clinical manifestations * Screening * Tools to test corneal sensitivity * Diagnostic algorithm * Disease staging * Considerations for referral Key Concepts: * Patients who are candidates for screening include those with a variety of genetic, system, central nervous system, or ocular diseases, such as diabetes mellitus, multiple sclerosis, and Alzheimer’s disease, or who us contact lenses or eyedrops with preservatives * Corneal sensitivity can be tested various ways and is critical to make the diagnosis * Cenegermin is self-administered and requires the patient be thoroughly educated regarding storage, handling, and administration
Overview
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der Managing Patients With Neurotrophic Keratitis (NK)-Community!